Memantine in neurological disorders – schizophrenia and depression

Memantine is used in Alzheimer’s disease treatment as a non-competitive modern-affinity strong voltage-dependent N-methyl-D-aspartate receptor antagonist. The fundamental role of these receptors is to bind glutamate: the main excitatory neurotransmitter in the brain, believed to play a crucial role...

Descripción completa

Detalles Bibliográficos
Autores principales: Czarnecka, Kamila, Chuchmacz, Jakub, Wójtowicz, Przemysław, Szymański, Paweł
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7900025/
https://www.ncbi.nlm.nih.gov/pubmed/33447926
http://dx.doi.org/10.1007/s00109-020-01982-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7900025/
https://www.ncbi.nlm.nih.gov/pubmed/33447926
http://dx.doi.org/10.1007/s00109-020-01982-z

Ejemplares similares